RadNet (NASDAQ:RDNT) Stock Rating Upgraded by Raymond James
Raymond James upgraded shares of RadNet (NASDAQ:RDNT – Free Report) from an outperform rating to a strong-buy rating in a report published on Wednesday morning, Marketbeat.com reports. They currently have $65.00 target price on the medical research company’s stock, down from their previous target price of $85.00. A number of other research analysts have also […]
Raymond James upgraded shares of RadNet (NASDAQ:RDNT – Free Report) from an outperform rating to a strong-buy rating in a report published on Wednesday morning, Marketbeat.com reports. They currently have $65.00 target price on the medical research company’s stock, down from their previous target price of $85.00. A number of other research analysts have also […]
